These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38199614)

  • 1. Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
    Slaunwhite A; Min JE; Palis H; Urbanoski K; Pauly B; Barker B; Crabtree A; Bach P; Krebs E; Dale L; Meilleur L; Nosyk B
    BMJ; 2024 Jan; 384():e076336. PubMed ID: 38199614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt.
    Min JE; Guerra-Alejos BC; Yan R; Palis H; Barker B; Urbanoski K; Pauly B; Slaunwhite A; Bach P; Ranger C; Heaslip A; Nosyk B
    JAMA Netw Open; 2024 May; 7(5):e2411389. PubMed ID: 38748421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study.
    Palis H; Xavier C; Dobrer S; Desai R; Sedgemore KO; Scow M; Lock K; Gan W; Slaunwhite A
    BMC Public Health; 2022 Nov; 22(1):2084. PubMed ID: 36380298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
    Pearce LA; Min JE; Piske M; Zhou H; Homayra F; Slaunwhite A; Irvine M; McGowan G; Nosyk B
    BMJ; 2020 Mar; 368():m772. PubMed ID: 32234712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
    Pauly BB; Kurz M; Dale LM; Macevicius C; Kalicum J; Pérez DG; McCall J; Urbanoski K; Barker B; Slaunwhite A; Lindsay M; Nosyk B
    J Subst Use Addict Treat; 2024 Jun; 161():209341. PubMed ID: 38490334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
    Nosyk B; Slaunwhite A; Urbanoski K; Hongdilokkul N; Palis H; Lock K; Min JE; Zhao B; Card KG; Barker B; Meilleur L; Burmeister C; Thomson E; Beck-McGreevy P; Pauly B
    BMJ Open; 2021 Jun; 11(6):e048353. PubMed ID: 34108170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.
    Palis H; Gan W; Xavier C; Desai R; Scow M; Sedgemore KO; Greiner L; Nicholls T; Slaunwhite A
    JAMA Netw Open; 2022 Nov; 5(11):e2243653. PubMed ID: 36416821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.
    Selfridge M; Card K; Kandler T; Flanagan E; Lerhe E; Heaslip A; Nguyen A; Moher M; Pauly B; Urbanoski K; Fraser C
    Int J Drug Policy; 2022 Jul; 105():103709. PubMed ID: 35525052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study.
    Palis H; Zhao B; Young P; Korchinski M; Greiner L; Nicholls T; Slaunwhite A
    Subst Abuse Treat Prev Policy; 2022 Nov; 17(1):77. PubMed ID: 36434706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study.
    Morrow RL; Bassett K; Maclure M; Dormuth CR
    BMJ Open; 2019 May; 9(5):e025567. PubMed ID: 31061028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.
    Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG
    Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada.
    MacDougall L; Smolina K; Otterstatter M; Zhao B; Chong M; Godfrey D; Mussavi-Rizi A; Sutherland J; Kuo M; Kendall P
    PLoS One; 2019; 14(1):e0210129. PubMed ID: 30629607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data.
    Liu EY; Tamblyn R; Filion KB; Buckeridge DL
    BMJ Open; 2021 Feb; 11(2):e042299. PubMed ID: 33602708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes.
    Xie J; Strauss VY; Martinez-Laguna D; Carbonell-Abella C; Diez-Perez A; Nogues X; Collins GS; Khalid S; Delmestri A; Turkiewicz A; Englund M; Tadrous M; Reyes C; Prieto-Alhambra D
    JAMA; 2021 Oct; 326(15):1504-1515. PubMed ID: 34665205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.
    Barocas JA; Wang J; Marshall BDL; LaRochelle MR; Bettano A; Bernson D; Beckwith CG; Linas BP; Walley AY
    Drug Alcohol Depend; 2019 Jul; 200():59-63. PubMed ID: 31100636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
    BMJ; 2024 Mar; 384():q615. PubMed ID: 38467406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.